Authors: SIMKO RJ STANEK EJ

Citation: Rj. Simko et Ej. Stanek, TREATMENT PATTERNS FOR HEART-FAILURE IN A PRIMARY-CARE ENVIRONMENT, American journal of managed care, 3(11), 1997, pp. 1669-1676

Authors: STANEK EJ SIMKO RJ DENOFRIO D PAVRI BB

Citation: Ej. Stanek et al., PROLONGED QUINIDINE HALF-LIFE WITH ASSOCIATED TOXICITY IN A PATIENT WITH HEPATIC-FAILURE, Pharmacotherapy, 17(3), 1997, pp. 622-625

Authors: STANEK EJ CHENG JWM PEEPLES PJ SIMKO RJ SPINLER SA

Citation: Ej. Stanek et al., PATIENT PREFERENCES FOR THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION, Medical decision making, 17(4), 1997, pp. 464-471

Authors: SIMKO RJ TSUNG FFW STANEK EJ

Citation: Rj. Simko et al., ACTIVATED CLOTTING TIME VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR THERAPEUTIC MONITORING OF HEPARIN, The Annals of pharmacotherapy, 29(10), 1995, pp. 1015-1021

Authors: BHARGAVA HN MATWYSHYN GA GERK PM BOZEK PS BAILEY MD KO KH SIMKO RJ THORAT SN

Citation: Hn. Bhargava et al., EFFECTS OF NALTREXONE PELLET IMPLANTATION ON MORPHINE-TOLERANCE AND PHYSICAL-DEPENDENCE IN THE RAT, General pharmacology, 25(1), 1994, pp. 149-155